
The global Bioresorbable Ocular Implant market size is predicted to grow from US$ 357 million in 2025 to US$ 531 million in 2031; it is expected to grow at a CAGR of 6.8% from 2025 to 2031.
Ocular implants — small devices designed to be inserted into the eye and deliver a drug locally over an extended period — are rapidly gaining ground as a treatment option. As patients continue to seek out convenient, less invasive treatments, the demand for these implants will continue to increase. Bioresorbable implants are inserted into the patient’s eye and safely absorbed by the body over time. These implants combine a drug with a polymer — often polylactic-co-glycolic acid (PLGA) — which degrades over time, releasing a drug.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
publisher, Inc. (LPI) ' newest research report, the “Bioresorbable Ocular Implant Industry Forecast” looks at past sales and reviews total world Bioresorbable Ocular Implant sales in 2024, providing a comprehensive analysis by region and market sector of projected Bioresorbable Ocular Implant sales for 2025 through 2031. With Bioresorbable Ocular Implant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioresorbable Ocular Implant industry.
This Insight Report provides a comprehensive analysis of the global Bioresorbable Ocular Implant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioresorbable Ocular Implant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioresorbable Ocular Implant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioresorbable Ocular Implant and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioresorbable Ocular Implant.
This report presents a comprehensive overview, market shares, and growth opportunities of Bioresorbable Ocular Implant market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Anterior Drug Delivery Methods
Posterior Drug Delivery Methods
Segmentation by Application:
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim
Allergan
Re-Vana Therapeutics
PolyActiva
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bioresorbable Ocular Implant market?
What factors are driving Bioresorbable Ocular Implant market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bioresorbable Ocular Implant market opportunities vary by end market size?
How does Bioresorbable Ocular Implant break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bioresorbable Ocular Implant Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bioresorbable Ocular Implant by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bioresorbable Ocular Implant by Country/Region, 2020, 2024 & 2031
2.2 Bioresorbable Ocular Implant Segment by Type
2.2.1 Anterior Drug Delivery Methods
2.2.2 Posterior Drug Delivery Methods
2.3 Bioresorbable Ocular Implant Sales by Type
2.3.1 Global Bioresorbable Ocular Implant Sales Market Share by Type (2020-2025)
2.3.2 Global Bioresorbable Ocular Implant Revenue and Market Share by Type (2020-2025)
2.3.3 Global Bioresorbable Ocular Implant Sale Price by Type (2020-2025)
2.4 Bioresorbable Ocular Implant Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Bioresorbable Ocular Implant Sales by Application
2.5.1 Global Bioresorbable Ocular Implant Sale Market Share by Application (2020-2025)
2.5.2 Global Bioresorbable Ocular Implant Revenue and Market Share by Application (2020-2025)
2.5.3 Global Bioresorbable Ocular Implant Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Bioresorbable Ocular Implant Breakdown Data by Company
3.1.1 Global Bioresorbable Ocular Implant Annual Sales by Company (2020-2025)
3.1.2 Global Bioresorbable Ocular Implant Sales Market Share by Company (2020-2025)
3.2 Global Bioresorbable Ocular Implant Annual Revenue by Company (2020-2025)
3.2.1 Global Bioresorbable Ocular Implant Revenue by Company (2020-2025)
3.2.2 Global Bioresorbable Ocular Implant Revenue Market Share by Company (2020-2025)
3.3 Global Bioresorbable Ocular Implant Sale Price by Company
3.4 Key Manufacturers Bioresorbable Ocular Implant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bioresorbable Ocular Implant Product Location Distribution
3.4.2 Players Bioresorbable Ocular Implant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Bioresorbable Ocular Implant by Geographic Region
4.1 World Historic Bioresorbable Ocular Implant Market Size by Geographic Region (2020-2025)
4.1.1 Global Bioresorbable Ocular Implant Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bioresorbable Ocular Implant Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bioresorbable Ocular Implant Market Size by Country/Region (2020-2025)
4.2.1 Global Bioresorbable Ocular Implant Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bioresorbable Ocular Implant Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bioresorbable Ocular Implant Sales Growth
4.4 APAC Bioresorbable Ocular Implant Sales Growth
4.5 Europe Bioresorbable Ocular Implant Sales Growth
4.6 Middle East & Africa Bioresorbable Ocular Implant Sales Growth
5 Americas
5.1 Americas Bioresorbable Ocular Implant Sales by Country
5.1.1 Americas Bioresorbable Ocular Implant Sales by Country (2020-2025)
5.1.2 Americas Bioresorbable Ocular Implant Revenue by Country (2020-2025)
5.2 Americas Bioresorbable Ocular Implant Sales by Type (2020-2025)
5.3 Americas Bioresorbable Ocular Implant Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bioresorbable Ocular Implant Sales by Region
6.1.1 APAC Bioresorbable Ocular Implant Sales by Region (2020-2025)
6.1.2 APAC Bioresorbable Ocular Implant Revenue by Region (2020-2025)
6.2 APAC Bioresorbable Ocular Implant Sales by Type (2020-2025)
6.3 APAC Bioresorbable Ocular Implant Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bioresorbable Ocular Implant by Country
7.1.1 Europe Bioresorbable Ocular Implant Sales by Country (2020-2025)
7.1.2 Europe Bioresorbable Ocular Implant Revenue by Country (2020-2025)
7.2 Europe Bioresorbable Ocular Implant Sales by Type (2020-2025)
7.3 Europe Bioresorbable Ocular Implant Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bioresorbable Ocular Implant by Country
8.1.1 Middle East & Africa Bioresorbable Ocular Implant Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bioresorbable Ocular Implant Revenue by Country (2020-2025)
8.2 Middle East & Africa Bioresorbable Ocular Implant Sales by Type (2020-2025)
8.3 Middle East & Africa Bioresorbable Ocular Implant Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bioresorbable Ocular Implant
10.3 Manufacturing Process Analysis of Bioresorbable Ocular Implant
10.4 Industry Chain Structure of Bioresorbable Ocular Implant
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bioresorbable Ocular Implant Distributors
11.3 Bioresorbable Ocular Implant Customer
12 World Forecast Review for Bioresorbable Ocular Implant by Geographic Region
12.1 Global Bioresorbable Ocular Implant Market Size Forecast by Region
12.1.1 Global Bioresorbable Ocular Implant Forecast by Region (2026-2031)
12.1.2 Global Bioresorbable Ocular Implant Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bioresorbable Ocular Implant Forecast by Type (2026-2031)
12.7 Global Bioresorbable Ocular Implant Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Bioresorbable Ocular Implant Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Bioresorbable Ocular Implant Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Allergan
13.2.1 Allergan Company Information
13.2.2 Allergan Bioresorbable Ocular Implant Product Portfolios and Specifications
13.2.3 Allergan Bioresorbable Ocular Implant Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Allergan Main Business Overview
13.2.5 Allergan Latest Developments
13.3 Re-Vana Therapeutics
13.3.1 Re-Vana Therapeutics Company Information
13.3.2 Re-Vana Therapeutics Bioresorbable Ocular Implant Product Portfolios and Specifications
13.3.3 Re-Vana Therapeutics Bioresorbable Ocular Implant Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Re-Vana Therapeutics Main Business Overview
13.3.5 Re-Vana Therapeutics Latest Developments
13.4 PolyActiva
13.4.1 PolyActiva Company Information
13.4.2 PolyActiva Bioresorbable Ocular Implant Product Portfolios and Specifications
13.4.3 PolyActiva Bioresorbable Ocular Implant Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 PolyActiva Main Business Overview
13.4.5 PolyActiva Latest Developments
14 Research Findings and Conclusion
Ěý
Ěý
*If Applicable.
